Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular pathogenesis of osteosarcoma.

Maya Kansara1, David M Thomas

  • 1Ian Potter Foundation Centre for Cancer Genomics and Predictive Medicine and Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.

DNA and Cell Biology
|February 1, 2007
PubMed
Summary

Osteosarcoma research has advanced cancer biology and treatment over 30 years. Key gene discoveries and chemotherapy have improved survival for this rare bone cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

Future oncology (London, England)·2026
Same author

Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma.

JTO clinical and research reports·2026
Same author

BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacy.

International journal of clinical oncology·2026
Same author

Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results.

Psycho-oncology·2026
Same author

Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature.

Hereditary cancer in clinical practice·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a rare but severe bone cancer.
  • Research over 30 years has significantly advanced understanding and treatment.
  • Key discoveries include tumor suppressor genes and DNA helicases in familial syndromes.

Purpose of the Study:

  • To provide a comprehensive overview of osteosarcoma's molecular causes.
  • To highlight significant research contributions over the past three decades.
  • To suggest future research directions in osteosarcoma.

Main Methods:

  • Literature review of osteosarcoma research.
  • Analysis of key genetic factors and their roles.
  • Examination of advancements in clinical management, including chemotherapy.

Main Results:

  • Insights into critical cancer genes like retinoblastoma tumor suppressor gene and TP53.
  • Identification of familial cancer syndromes linked to DNA helicases.
  • Demonstrated improvements in patient survival through adjuvant chemotherapy.

Conclusions:

  • Significant progress has been made in understanding osteosarcoma's molecular underpinnings.
  • Adjuvant chemotherapy has dramatically improved survival rates.
  • Further research is crucial for continued advancements in osteosarcoma management.

Related Experiment Videos